CRSP vs SPG · rev $11.6M vs rev $3.55B
Crispr Therapeutics AG (CRSP) versus SPG (SPG) — a side-by-side from cached financials, not a winner call.
Crispr Therapeutics AG (CRSP) is a biotechnology company listed on US.
SPG (SPG) common stock.
Latest reported CRSP revenue for 2026-06-30 was $11.6M. Net income was -$214.1M. CRSP currently screens at market cap $5.42B.
Latest reported SPG revenue for 2026-06-30 was $3.55B. Net income was $1.14B. SPG currently screens at market cap $0.
CRSP currently screens at market cap $5.42B. SPG currently screens at market cap $0.
Not investment advice. Open the CRSP and SPG stock pages for the full models.
Not investment advice.